Oral lactoferrin in the treatment of respiratory disorders

Details Oral lactoferrin in the treatment of respiratory disorders Oral lactoferrin in the treatment of respiratory disorders

2007-07-03

2007-07-03

Fay, Zohreh A. (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S566000

Reexamination Certificate

active

10441329

ABSTRACT:
The present invention relates to methods of treating an allergic or non-allergic respiratory disorder by administering orally a composition of lactoferrin alone or in combination with metal chelators to treat respiratory disorders.

REFERENCES:
patent: 4977137 (1990-12-01), Nichols et al.
patent: 5198419 (1993-03-01), Ando et al.
patent: 5571691 (1996-11-01), Conneely et al.
patent: 5571697 (1996-11-01), Conneely et al.
patent: 5571896 (1996-11-01), Conneely et al.
patent: 5676930 (1997-10-01), Jager et al.
patent: 5766939 (1998-06-01), Conneely et al.
patent: 5849881 (1998-12-01), Conneely et al.
patent: 5916900 (1999-06-01), Cupps et al.
patent: 5955316 (1999-09-01), Conneely et al.
patent: 6080559 (2000-06-01), Conneely et al.
patent: 6100054 (2000-08-01), Conneely et al.
patent: 6111081 (2000-08-01), Conneely et al.
patent: 6228614 (2001-05-01), Conneely et al.
patent: 6399570 (2002-06-01), Mann
patent: 6635447 (2003-10-01), Conneely et al.
patent: 2003/0105006 (2003-06-01), Mann
patent: 2003/0190303 (2003-10-01), Kimber et al.
patent: 2004/0009895 (2004-01-01), Varadhachary et al.
patent: 2004/0082504 (2004-04-01), Varadhachary et al.
patent: 2004/0142037 (2004-07-01), Engel Mayer et al.
patent: 2005/0064546 (2005-03-01), Conneely et al.
patent: 2005/0075277 (2005-04-01), Varadhachary et al.
patent: WO-9844940 (1998-10-01), None
Elrod et al, “Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep,” Am J Respir Crit care Med vol. 156, 1997, pp. 375-381.
Thomas et al, “Immobilized Lactoferrin is a Stimulus for Eosinophil Activation,” The Journal of Immunology 2002, pp. 993-999.
Rice et al, “Inhibitors of Tryptase for the treatment of Mast Cell-Mediated Diseases,” Current Pharmaceutical Design vol. 4, 1998, pp. 381-396.
U.S. Appl. No. 10/733,621, filed Dec. 11, 2003
U.S. Appl. No. 10/728,521, filed Dec. 5, 2003.
U.S. Appl. No. 10/862,213, filed Jun. 7, 2004.
U.S. Appl. No. 10/728,275, filed Dec. 4, 2003.
U.S. Appl. No. 10/844,865, filed Aug. 21, 2003.
U.S. Appl. No. 10/732,429, filed Dec. 9, 2003.

Affiliated with

Also associated with

Rating

Oral lactoferrin in the treatment of respiratory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral lactoferrin in the treatment of respiratory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral lactoferrin in the treatment of respiratory disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3822281